Biotech Penny Stocks to Watch: Key Takeaways
- The future catalyst that could bring more volume and demand to biotechs…
- Why PR pumping machine TSOI is back on the watchlist after a brief hiatus…
- Learn from my wins and losses — review my trade examples in stocks #2 and #3 (details below)…
This week I’m watching a fresh batch of biotech penny stocks. They have news, and they’re multi-day runners. And I traded two of them. Dig into my watchlist below to find out what’s hot and what you can learn from ALL my trades. Let’s go!
- Leap Therapeutics, Inc. (NASDAQ: LPTX … Read our full analysis here.)
- Halberd Corporation (OTCPK: HALB … Read our full analysis here.)
- Therapeutic Solutions International, Inc. (OTCPK: TSOI … Read our full analysis here.)
- BELLUS Health Inc. (NASDAQ: BLU … Read our full analysis here.)
- Adhera Therapeutics, Inc. (OTCPK: ATRX … Read our full analysis here.)
- Matinas BioPharma Holdings, Inc. (NYSE: MTNB … Read our full analysis here.)
- CytoDyn Inc. (OTCQB: CYDY … Read our full analysis here.)
- NanoViricides, Inc. (NYSE: NNVC … Read our full analysis here.)
Remember you have just 1 life so you must do EVERYTHING possible to make it the best life possible, for you & your family. Sadly too many people don’t put in the time required for massive success because they don’t do what they truly love, so learn from their mistakes/do better!
— Timothy Sykes (@timothysykes) September 14, 2021
Table of Contents
- 1 Top Biotech Penny Stocks to Watch
- 1.1 Biotech Penny Stocks #1: Leap Therapeutics, Inc. (NASDAQ: LPTX)
- 1.2 Biotech Penny Stocks #2: Halberd Corporation (OTCPK: HALB)
- 1.3 Biotech Penny Stocks #3: Therapeutic Solutions International, Inc. (OTCPK: TSOI)
- 1.4 Biotech Penny Stocks #4: BELLUS Health Inc. (NASDAQ: BLU)
- 1.5 Biotech Penny Stocks #5: Adhera Therapeutics, Inc. (OTCPK: ATRX)
- 1.6 Biotech Penny Stocks #6: Matinas BioPharma Holdings, Inc. (NYSE: MTNB)
- 1.7 Biotech Penny Stocks #7: CytoDyn Inc. (OTCQB: CYDY)
- 1.8 Biotech Penny Stocks #8: NanoViricides, Inc. (NYSE: NNVC)
- 2 Get the List of Penny Stocks I’m Watching Delivered to Your Inbox
- 3 Conclusion
Top Biotech Penny Stocks to Watch
These are the top stocks on my watchlist. ‘Watch’ is the key word here. There’s no guarantee that there’ll be a trading opportunity. Remember, these stocks move FAST.
Before we get to my list of stocks to watch, here are a few of my top resources for penny stocks…
- If you’re new to penny stocks, start here with this FREE online guide.
- Ready to learn how to build your own stock watchlist? This post is for you.
- Discover how I find all the stocks on my watchlists here.
How do I find hot stocks? I use StocksToTrade every day. For me, it’s the best tool because I helped design it specifically for trading penny stocks. (I’m also an investor.) It has awesome charts, built-in scans, social media feeds, and so much more to help you do your research.
Now, let’s get to the top biotech penny stocks to watch this week…
Biotech Penny Stocks #1: Leap Therapeutics, Inc. (NASDAQ: LPTX)
LPTX develops cancer treatments.
On September 13 the company announced it will present data from its Phase 2a clinical trial at the European Society for Medical Oncology Congress, on September 16. (Because of the time difference, that’s at 2:30 a.m. Eastern.) The company will also hold a conference call on September 17 to discuss the results.
The stock traded high volume the day of the press release. I’ll watch for a reaction to the conference presentation. Ideally, it’ll break out over $1.90 with high volume.
Biotech Penny Stocks #2: Halberd Corporation (OTCPK: HALB)
HALB develops treatments for COVID-19, brain injuries, Alzheimer’s disease, and cancer.
On September 13 the company announced its treatment “eradicates the building blocks of Alzheimer’s disease.”
I dip-bought it in the morning and my goal was to sell into a bounce to its earlier highs. It hit a wall of sellers around 4 cents and I had to cut it for a $59 loss. It’s fine. Small losses are OK. I’ll always protect my account by cutting losses quickly.
Remember, no trader wins 100% of the time. I’ve been trading for over 20 years and I only win roughly 77% of the time.* (See all my trades and win rate here.*)
HALB’s a former runner so I thought it could spike. But it’s stuck in a channel between 3 cents and $0.045. I’ll watch for it to break out or break down out of the channel before planning another trade.
Biotech Penny Stocks #3: Therapeutic Solutions International, Inc. (OTCPK: TSOI)
TSOI develops immune modulation agents to treat various diseases.
I traded TSOI on September 10. That’s when the company announced it hired Venvalo Group to help it implement its COVID-19 Phase 3 clinical trials.
I bought 95,000 shares at 8 cents and sold at $0.084 for a profit of $380.* It was a decent trade for a non-volatile stock. I took a single. And when I keep my losses smaller than my wins, my small gains can add up over time.
The company continues to pump out press releases almost daily. It announced it successfully treated a veteran with stem cells to treat chronic traumatic encephalopathy on September 13.
I’ll keep watching TSOI for a pattern, but I want to see high volume for more potential upside.
Biotech Penny Stocks #4: BELLUS Health Inc. (NASDAQ: BLU)
BLU develops chronic cough treatments.
The company announced positive interim analysis from its Phase 2b trial on September 13.
Roberto Bellini, BLU president and CEO said, “We believe the encouraging SOOTHE Phase 2b trial interim analysis will enable us to accelerate the planning for our Phase 3 program while awaiting SOOTHE final results.”
The stock had a morning panic after the gap up in premarket on September 13. Then it bounced back to new daily highs. The next day it left penny stock territory. It had a morning spike and short squeeze. BLU made a high of $6.34 before fading.
I’ll watch BLU for a dip buy into any big panic.
Biotech Penny Stocks #5: Adhera Therapeutics, Inc. (OTCPK: ATRX)
ATRX is a clinical-stage biotech company.
It provided an update on its corporate strategy on September 13. The announcement also included an update on the company’s plans to develop its Parkinson’s disease and diabetes treatment.
The stock spiked on the news, but the next day it failed. I’ll watch it for a panic dip buy.
Biotech Penny Stocks #6: Matinas BioPharma Holdings, Inc. (NYSE: MTNB)
MTNB’s another clinical-stage biotech. It develops a lipid nanocrystal platform delivery technology.
On September 13 the company announced positive efficacy and safety data from the first two cohorts of patients in its cryptococcal meningitis trial.
CEO Jerome D. Jabbour said, “These results are a major milestone for Matinas, MAT2203 and our LNC platform delivery technology.”
The next day the company announced the CEO will present at the H.C. Wainwright 23rd Annual Global Investment Conference on September 13–15.
The stock’s uptrending and went from roughly 80 cents to $1.20 in three days. It’s not very volatile but it’s a multi-day runner. I won’t chase it. I’ll watch for a dip buy into an intraday panic.
Biotech Penny Stocks #7: CytoDyn Inc. (OTCQB: CYDY)
CYDY develops antibodies designed to fight HIV, inflammation, autoimmune diseases, and cancer.
It’s another stock with multiple catalysts … The company announced it treated the first patient in its Phase 3 COVID-19 trial on September 9. And on September 13, it announced company officers will provide a “comprehensive business update” at the Emerging Growth Conference on September 15 at 3:30 p.m. Eastern.
The stock had its first green day on September 13, but it failed the next day. I’ll watch for the stock’s reaction to the conference presentation. If high volume comes in, it could break out over $1.70.
Biotech Penny Stocks #8: NanoViricides, Inc. (NYSE: NNVC)
NNVC develops drugs to fight viral infections.
The stock spiked in premarket on September 14 after the company announced it completed licensing the coronavirus field for drug development.
“The licensed field includes antiviral drugs to treat SARS-CoV-2 and its variants that cause the COVID-19 disease.”
The stock has a history of failed spikes, so it’s on watch for a dip buy into a big panic.
Get the List of Penny Stocks I’m Watching Delivered to Your Inbox
Want to know which stocks I’m watching each week? Subscribe to my no-cost watchlist. I’ll send my top penny stocks to watch right to your inbox every week. It can help you learn the process I follow for every stock.
I’ll say it again … The stocks on my watchlist aren’t an automatic buy. Remember to do your own due diligence and research. If you’re trading without a trading plan, you’re gambling. Don’t be a degenerate gambler — trade smart!
👉🏼 SUBSCRIBE to my no-cost weekly stock watchlist here.
Biotech penny stocks are stocks of small, developmental companies. These companies are usually desperate for cash. They need it to continue developing products and for testing and trials. Trade them with caution…
They’re known to be extremely volatile. They can have huge price swings. One minute they’re flying high on positive news — the next they’re down due to bad trial results, side effects, or stock dilution.
If you’re prepared to take advantage of the price swings, these stocks can offer great trading opportunities…
In my Trading Challenge chat room, my students and I talk about the hottest penny stocks. And many top traders who got their start in the Challenge are now chat moderators who answer questions and help out new students.
If you want to join a community of top traders, apply for my Trading Challenge. I don’t accept everyone. I only want the most dedicated students who are willing to put in the time and effort it takes to become my next top student. Could it be you?
What do you think of these biotech penny stocks to watch? Let me know in the comments … I love to hear from you!
*Results are not typical and will vary from person to person. Making money trading stocks takes time, dedication, and hard work. Most who receive free or paid content will make little or no money because they will not apply the skills being taught. Any results displayed are exceptional. We do not guarantee any outcome regarding your earnings or income as the factors that impact such results are numerous and uncontrollable.
**Tim Sykes has a minority ownership stake in StockstoTrade.com.